ISSN Portal
The Keepers Registry (preservation)
SHERPA/RoMEO (access policies)
Future Oncology
container_7igbpq2qy5fjrfsqe7jmn7rwyy
Future Medicine
Homepage URLs
https://www.futuremedicine.com/loi/fon |
Example Publications
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion
Marco Boeri, Anna Purdum, Jessie Sutphin, Brett Hauber, James A. Kaye
2021
|
Future Oncology
doi:10.2217/fon-2021-0160 pmid:34581197
Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study
Paul Richardson, Simon J Harrison, Sara Bringhen, Fredrik Schjesvold, Kwee Yong, Frank Campana, Solenn Le-Guennec, Sandrine Macé, Meletios A Dimopoulos
2021
|
Future Oncology
doi:10.2217/fon-2021-0568 pmid:34521277
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
PILAR GARRIDO, JEAN LOUIS PUJOL, Edward Kim, Jay M Lee, Masahiro Tsuboi, Ana Gómez-Rueda, Amparo Benito, Nicolas Moreno, Luis Gorospe, Tuochuan Dong, Cecile Blin, Vanessa Rodrik - Outmezguine
(+2 others)
2021
|
Future Oncology
doi:10.2217/fon-2020-1098 pmid:33648347
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma
Jatin Shah, Sharon Shacham, Michael Kauffman, Patrick Daniele, Dimitrios Tomaras, Gabriel Tremblay, Rene-Olivier Casasnovas, Marie Maerevoet, Josee Zijlstra, George Follows, Joost S. P Vermaat, Nagesh Kalakonda
(+24 others)
2021
|
Future Oncology
doi:10.2217/fon-2020-0946 pmid:33528286
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic
Srdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, Martin Ellis, Laura Fox, Yeow T Goh, Vikas Gupta, Claire Harrison, Jean-Jacques Kiladjian, Mihaela C Lazaroiu, Adam Mead, Donal McLornan
(+9 others)
2021
|
Future Oncology
doi:10.2217/fon-2020-1048 pmid:33423550
4,477
Known Releases
Preservation Summary [more]
| 333 | preserved and accessble (bright) | |
| 2,793 | preserved, inaccessible (dark) | |
| 1,351 | no known preservation |
Lookup Links